Lixte Biotechnology Holdings, Inc. is a clinical stage public pharmaceutical company dedicated to discovering drugs for more effective treatments for cancer. Lixte has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models. The current drug portfolio includes inhibitors of protein phosphatases that are critical to cell division and DNA damage repair and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation.
Quote | Lixte Biotechnology Holdings Inc. (OTCMKTS:LIXT)
Last: | $3.74 |
---|---|
Change Percent: | 0.0% |
Open: | $4 |
Close: | $3.74 |
High: | $4.125 |
Low: | $3.7 |
Volume: | 106,267 |
Last Trade Date Time: | 11/26/2020 04:55:13 pm |
News | Lixte Biotechnology Holdings Inc. (OTCMKTS:LIXT)
Clinical trial to test recent findings that show LIXTE’s lead clinical compound, LB-100, increases recognition of colon cancer cells by the immune system PASADENA, CA, June 14, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the ...
Clinical trial to test recent findings that show LIXTE’s lead clinical compound, LB-100, increases recognition of colon cancer cells by the immune system PASADENA, CA, June 14, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the ȁ...
Message Board Posts | Lixte Biotechnology Holdings Inc. (OTCMKTS:LIXT)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $LIXT News Article - LIXTE Biotechnology Announces Sarah Cannon Research Institute Join | whytestocks | investorshangout | 04/04/2023 4:00:47 PM |
Amazing to watch 1.64 to flat same day. | Mr Rollup | investorshub | 02/11/2023 12:52:53 AM |
$LIXT......................................https://stockcharts.com/h-sc/ui?s=$LIXT | glenn1919 | investorshub | 02/10/2023 9:28:35 PM |
$LIXT NEWS 1.50'S | TheFinalCD | investorshub | 02/10/2023 3:00:00 PM |
$LIXT: Just more "HYPER-STIMULATION" of the PRICE of | Invest-in-America | investorshub | 02/10/2023 2:59:36 PM |
News, Short Squeeze, Breakout and More Instantly...
Lixte Biotechnology Holdings Inc. Company Name:
LIXT Stock Symbol:
OTCMKTS Market:
Lixte Biotechnology Holdings Inc. Website:
Clinical trial to test recent findings that show LIXTE’s lead clinical compound, LB-100, increases recognition of colon cancer cells by the immune system PASADENA, CA, June 14, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the ...
Clinical trial to test recent findings that show LIXTE’s lead clinical compound, LB-100, increases recognition of colon cancer cells by the immune system PASADENA, CA, June 14, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the ȁ...
LB-100 Generates Neo-Antigens in Cancer Cells that are Presented to the Immune System by Disrupting the Process of RNA Splicing PASADENA, CA, June 06, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the “Company”) ( ...